Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it …
Less than two months into the year, Teva Pharmaceutical Industries Ltd.’s new chief has already effectively written off a …
If you have even a hint of a contrarian personality, you should look no further than the pharmaceutical industry. Thanks to various scandals and controversies like the one impacting Valeant Pharmaceuticals Intl Inc (NYSE:VRX), plenty of big …
Warren Buffett and Berkshire Hathaway disclosed an almost $400 million stake in Teva Pharmaceutical after the market close on Wednesday, sending the shares soaring. The big stock increase crushed short sellers, who were sitting on a …
Teva Pharmaceutical Industries Ltd., which has been without a permanent CEO for six months, revealed the full extent of the challenges facing its next leader by announcing more job cuts, a retreat from 45 markets and a steep cut to its …
Teva stock lost 13% value Sunday morning as the Israeli stock market began trading. Sunday's drop comes as Teva is on the ropes due to new competition. Teva suffered a major blow as pharmaceutical rival Mylan N.V. reported after close of …
Teva Pharmaceutical Industries shares rose Monday after the drugmaker said it was shaking up its top leadership to address pricing challenges and large debt from the $40.5 billion acquisition of Allergan’s generics business last year. …
Teva Pharmaceutical Industries Ltd (ADR)’s lowered outlook includes earnings per share ranging from $3.77 to $3.87. It was previously expecting 2017 earnings per share between $4.30 and $4.50. This is bad news for TEVA stock as Wall …